Abstract
Iron oxide nanoparticles are a useful diagnostic contrast agent and have great potential for therapeutic applications. Multiple emerging diagnostic and therapeutic applications and the numerous versatile parameters of the nanoparticle platform require a robust biological model for characterization and assessment. Here we investigate the use of iron oxide nanoparticles that target tumor vasculature, via the tumstatin peptide, in a novel three-dimensional tissue culture model. The developed tissue culture model more closely mimics the in vivo envi-ronment with a leaky endothelium coating around a glioma tumor mass. Tumstatin-iron oxide nanoparticles showed penetration and selective targeting to endothelial cell coating on the tumor in the three-dimensional model, and had approximately 2 times greater uptake in vitro and 2.7 times tumor neo-vascularization inhibition. Tumstatin provides targeting and thera-peutic capabilities to the iron oxide nanoparticle diagnostic contrast agent platform. And the novel endothelial cell-coated tumor model provides an in vitro microtissue environment to evaluate nanoparticles without moving into costly and time-consuming animal models. © Ivyspring International Publisher.
| Original language | English |
|---|---|
| Pages (from-to) | 66-75 |
| Journal | Theranostics |
| Volume | 2 |
| Issue number | 1 |
| Online published | 1 Jan 2012 |
| DOIs | |
| Publication status | Published - 2012 |
| Externally published | Yes |
Research Keywords
- Anti-angiogenesis
- Drug delivery
- Imaging
- Iron oxide nanoparticles
- Magnetic
- Multicellular tumor spheroids
- Nanoparticle
- Theranostic
- Tumor penetration
- Tumstatin
Publisher's Copyright Statement
- This full text is made available under CC-BY-NC 4.0. https://creativecommons.org/licenses/by-nc/4.0/